Business Context and Reporting Period
This Form 8-K, filed on February 23, 2023, by Bio-Rad Laboratories, Inc. (Bio-Rad), serves as a Regulation FD disclosure. It provides an update regarding Bio-Rad's investment in Sartorius AG, referencing Sartorius's financial results for the year ended December 31, 2022, which were publicly disclosed by Sartorius on February 17, 2023.
Key Financial Metrics (Sartorius AG)
The filing summarizes Sartorius AG's financial data for the year ended December 31, 2022, in millions of Euros (€), prepared under IFRS:
- Sales Revenue: €4,174.7
- Gross Profit: €2,196.5
- EBIT: €1,064.8
- Net Profit: €913.1
- Operating Cash Flow: €734.2
- Investing Cash Flow: (€1,129.9)
- Financing Cash Flow: €209.9
- Total Assets: €6,977.8 (Current: €2,023.2; Non-current: €4,954.6)
- Total Liabilities: €4,318.9 (Current: €1,803.4; Non-current: €2,515.5)
- Equity: €2,658.9
Material Changes
The filing does not provide comparative data for prior periods or specific year-over-year percentage changes for Sartorius AG. It solely presents the absolute financial figures for the 2022 fiscal year as disclosed by Sartorius.
Guidance, Outlook, and Risks
Bio-Rad explicitly states it does not assume any responsibility or liability for errors or omissions in the information publicly disclosed by Sartorius. The filing directs investors to Sartorius's 2022 Annual Report for further details and notes that the Sartorius website is not incorporated by reference into this report. No forward-looking guidance or specific risk factors regarding the investment are detailed in this document beyond the standard disclaimer.
Key Facts for Investor Verification
- Verify the full 2022 Annual Report of Sartorius AG for detailed segment performance and risk factors.
- Confirm the exchange rate impact when converting Sartorius's Euro-denominated results to USD for Bio-Rad's consolidated reporting.
- Review Bio-Rad's Form 10-K (filed February 17, 2023) for the original disclosure context regarding the investment in Sartorius AG.
- Note that Bio-Rad disclaims liability for the accuracy of the Sartorius data presented in this 8-K.